Share Price and Basic Stock Data
Last Updated: December 12, 2025, 8:31 pm
| PEG Ratio | -1.09 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Morarka Finance Ltd operates in the non-banking financial sector, an industry that has faced its share of challenges and opportunities. As of the latest reporting period, the company’s market capitalization stood at ₹35.4 Cr, with a share price of ₹78.8. Over the past few years, Morarka has seen fluctuating revenue figures, with sales reported at ₹5.86 Cr for FY 2023, a slight increase from ₹4.48 Cr in FY 2022. However, the revenue trajectory appears inconsistent, highlighted by a significant drop to ₹2.51 Cr in FY 2025. This trend raises questions about the sustainability of its revenue model. The company did show some resilience with a recovery in the last quarter of FY 2023, where sales surged to ₹5.13 Cr. Nevertheless, the overall revenue cycle remains uneven, which could pose concerns for potential investors looking for stability.
Profitability and Efficiency Metrics
Profitability metrics for Morarka Finance reflect a mixed performance. The company’s net profit for FY 2023 was ₹4.68 Cr, which is commendable against the backdrop of its earlier years but fell to ₹2.80 Cr in FY 2025. The operating profit margin (OPM) is quite strong at 51.72%, indicating effective cost management despite the variable sales figures. However, the return on equity (ROE) at 2.93% and return on capital employed (ROCE) at 3.29% suggest that the company is not fully utilizing its capital to generate profit, especially compared to industry norms. The inconsistent profitability can be attributed to fluctuating sales, which, while they have seen peaks, also exhibit significant troughs. This inconsistency in profitability could deter risk-averse investors, even though the overall margins appear solid.
Balance Sheet Strength and Financial Ratios
Morarka Finance’s balance sheet reveals a conservative yet stable financial position. The company has not reported any borrowings, which is a notable strength, reflecting a debt-free status that offers flexibility and lower financial risk. Reserves stood at ₹102.45 Cr, a significant buffer against unforeseen financial challenges. However, the price-to-book value (P/BV) ratio at 0.48x indicates the market may undervalue the stock compared to its book value of ₹211.65 per share. This could suggest a lack of confidence in future growth prospects or a mispricing in the market. Moreover, the current ratio is extraordinarily high at 21693.05, indicating an overwhelming capacity to cover short-term obligations, though this may also imply inefficient asset utilization. While the balance sheet appears strong, the low returns and high liquidity raise questions about the company’s operational efficiency.
Shareholding Pattern and Investor Confidence
In terms of ownership structure, Morarka Finance has a stable shareholding pattern, with promoters holding 66.77% of the equity as of March 2025. This high promoter stake can instill confidence among investors, suggesting that the management is committed to the company’s long-term vision. The public shareholding stands at 33.23%, indicating a reasonable level of retail participation. However, the number of shareholders has fluctuated, increasing to 4,171 by September 2025, which could signal growing interest or confidence in the stock. Despite this, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) could be a red flag, suggesting that larger investors remain cautious about the stock’s future. The reliance on retail investors, while beneficial for stability, may expose the company to volatility based on market sentiment.
Outlook, Risks, and Final Insight
The outlook for Morarka Finance is tempered with both opportunities and risks. On one hand, the company’s debt-free status and strong operating margins provide a solid foundation. On the other hand, the volatility in revenue and profit figures raises concerns about its growth sustainability. Investors should be aware of the risks associated with fluctuating sales, which could undermine profitability and investor confidence. Furthermore, the reliance on a concentrated promoter stake without significant institutional backing may limit the stock’s appeal to larger investors. As Morarka navigates its path forward, it will need to demonstrate consistent revenue growth and effective capital utilization to attract a broader investor base. For retail investors, this stock may offer potential but comes with inherent risks that warrant careful consideration before diving in.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 12.7 Cr. | 1.27 | 1.91/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 8.73 Cr. | 0.87 | 9.18/0.85 | 25.7 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 442 Cr. | 136 | 269/126 | 80.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 15.4 Cr. | 16.8 | 34.4/15.0 | 11.5 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 38.6 Cr. | 85.8 | 165/74.8 | 20.7 | 238 | 1.16 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 29,093.09 Cr | 460.41 | 50.11 | 522.84 | 0.22% | 15.80% | 8.84% | 8.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.19 | 0.21 | 0.45 | 0.01 | 5.13 | 0.90 | 0.75 | 0.81 | 0.81 | 1.19 | 0.17 | 0.34 | 0.29 |
| Expenses | 0.11 | 0.06 | 0.11 | 0.10 | 0.13 | 0.08 | 0.13 | 0.12 | 0.13 | 0.11 | 0.15 | 0.16 | 0.14 |
| Operating Profit | 5.08 | 0.15 | 0.34 | -0.09 | 5.00 | 0.82 | 0.62 | 0.69 | 0.68 | 1.08 | 0.02 | 0.18 | 0.15 |
| OPM % | 97.88% | 71.43% | 75.56% | -900.00% | 97.47% | 91.11% | 82.67% | 85.19% | 83.95% | 90.76% | 11.76% | 52.94% | 51.72% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.23 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 5.08 | 0.15 | 0.34 | -0.09 | 5.00 | 0.82 | 0.62 | 0.69 | 1.67 | 1.08 | 0.02 | 0.41 | 0.15 |
| Tax % | 3.54% | 93.33% | 38.24% | 366.67% | 3.80% | 25.61% | 40.32% | 23.19% | 1.80% | 50.00% | -400.00% | -26.83% | 0.00% |
| Net Profit | 4.89 | 0.00 | 0.21 | -0.43 | 4.81 | 0.61 | 0.37 | 0.53 | 1.64 | 0.54 | 0.09 | 0.52 | 0.14 |
| EPS in Rs | 10.86 | 0.00 | 0.47 | -0.96 | 10.68 | 1.35 | 0.82 | 1.18 | 3.64 | 1.20 | 0.20 | 1.16 | 0.31 |
Last Updated: July 18, 2025, 1:55 pm
Below is a detailed analysis of the quarterly data for Morarka Finance Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.29 Cr.. The value appears to be declining and may need further review. It has decreased from 0.34 Cr. (Mar 2025) to 0.29 Cr., marking a decrease of 0.05 Cr..
- For Expenses, as of Jun 2025, the value is 0.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.16 Cr. (Mar 2025) to 0.14 Cr., marking a decrease of 0.02 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.15 Cr.. The value appears to be declining and may need further review. It has decreased from 0.18 Cr. (Mar 2025) to 0.15 Cr., marking a decrease of 0.03 Cr..
- For OPM %, as of Jun 2025, the value is 51.72%. The value appears to be declining and may need further review. It has decreased from 52.94% (Mar 2025) to 51.72%, marking a decrease of 1.22%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.23 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.23 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.15 Cr.. The value appears to be declining and may need further review. It has decreased from 0.41 Cr. (Mar 2025) to 0.15 Cr., marking a decrease of 0.26 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be increasing, which may not be favorable. It has increased from -26.83% (Mar 2025) to 0.00%, marking an increase of 26.83%.
- For Net Profit, as of Jun 2025, the value is 0.14 Cr.. The value appears to be declining and may need further review. It has decreased from 0.52 Cr. (Mar 2025) to 0.14 Cr., marking a decrease of 0.38 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.31. The value appears to be declining and may need further review. It has decreased from 1.16 (Mar 2025) to 0.31, marking a decrease of 0.85.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 12:52 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.05 | 0.18 | 0.67 | 2.75 | 0.96 | 5.43 | 1.27 | 4.48 | 5.86 | 7.58 | 2.51 | 1.99 |
| Expenses | 0.32 | 0.22 | 0.33 | 0.45 | 0.37 | 0.42 | 0.45 | 0.36 | 0.42 | 0.38 | 0.46 | 0.56 | 0.56 |
| Operating Profit | -0.32 | -0.17 | -0.15 | 0.22 | 2.38 | 0.54 | 4.98 | 0.91 | 4.06 | 5.48 | 7.12 | 1.95 | 1.43 |
| OPM % | -340.00% | -83.33% | 32.84% | 86.55% | 56.25% | 91.71% | 71.65% | 90.62% | 93.52% | 93.93% | 77.69% | 71.86% | |
| Other Income | 0.11 | 0.16 | 0.17 | 0.05 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 1.22 | 0.23 |
| Interest | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.24 | -0.01 | 0.02 | 0.27 | 2.38 | 0.54 | 4.98 | 0.92 | 4.06 | 5.48 | 7.12 | 3.17 | 1.66 |
| Tax % | -8.33% | 300.00% | 50.00% | 29.63% | 1.26% | 12.96% | 0.60% | 25.00% | 8.87% | 14.42% | 11.38% | 11.99% | |
| Net Profit | -0.21 | -0.04 | 0.01 | 0.18 | 2.34 | 0.47 | 4.95 | 0.69 | 3.69 | 4.68 | 6.32 | 2.80 | 1.29 |
| EPS in Rs | -0.47 | -0.09 | 0.02 | 0.40 | 5.20 | 1.04 | 10.99 | 1.53 | 8.20 | 10.40 | 14.04 | 6.22 | 2.87 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 19.23% | 95.74% | 0.00% | 65.22% | 48.78% | 48.08% | 42.72% | 16.07% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 80.95% | 125.00% | 1700.00% | 1200.00% | -79.91% | 953.19% | -86.06% | 434.78% | 26.83% | 35.04% | -55.70% |
| Change in YoY Net Profit Growth (%) | 0.00% | 44.05% | 1575.00% | -500.00% | -1279.91% | 1033.11% | -1039.25% | 520.84% | -407.95% | 8.21% | -90.74% |
Morarka Finance Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 48% |
| 5 Years: | -14% |
| 3 Years: | -18% |
| TTM: | -39% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 53% |
| 5 Years: | -11% |
| 3 Years: | -9% |
| TTM: | -59% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 24% |
| 3 Years: | -12% |
| 1 Year: | -44% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: December 4, 2025, 3:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 |
| Reserves | 4.57 | 4.53 | 4.54 | 4.72 | 7.06 | 6.98 | 11.93 | 68.72 | 264.83 | 185.47 | 158.36 | 90.79 | 102.45 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.05 | 0.06 | 0.04 | 0.07 | 0.07 | 0.11 | 0.08 | 0.21 | 0.53 | 0.92 | 1.04 | 0.90 | 1.32 |
| Total Liabilities | 9.12 | 9.09 | 9.08 | 9.29 | 11.63 | 11.59 | 16.51 | 73.43 | 269.86 | 190.89 | 163.90 | 96.19 | 108.27 |
| Fixed Assets | 0.09 | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 8.61 | 8.61 | 8.61 | 8.88 | 11.11 | 11.09 | 13.79 | 72.86 | 269.00 | 189.81 | 162.92 | 95.23 | 107.09 |
| Other Assets | 0.42 | 0.39 | 0.39 | 0.33 | 0.45 | 0.43 | 2.65 | 0.51 | 0.80 | 1.02 | 0.93 | 0.91 | 1.13 |
| Total Assets | 9.12 | 9.09 | 9.08 | 9.29 | 11.63 | 11.59 | 16.51 | 73.43 | 269.86 | 190.89 | 163.90 | 96.19 | 108.27 |
Below is a detailed analysis of the balance sheet data for Morarka Finance Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.50 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.50 Cr..
- For Reserves, as of Sep 2025, the value is 102.45 Cr.. The value appears strong and on an upward trend. It has increased from 90.79 Cr. (Mar 2025) to 102.45 Cr., marking an increase of 11.66 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1.32 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.90 Cr. (Mar 2025) to 1.32 Cr., marking an increase of 0.42 Cr..
- For Total Liabilities, as of Sep 2025, the value is 108.27 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 96.19 Cr. (Mar 2025) to 108.27 Cr., marking an increase of 12.08 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.05 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.05 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 107.09 Cr.. The value appears strong and on an upward trend. It has increased from 95.23 Cr. (Mar 2025) to 107.09 Cr., marking an increase of 11.86 Cr..
- For Other Assets, as of Sep 2025, the value is 1.13 Cr.. The value appears strong and on an upward trend. It has increased from 0.91 Cr. (Mar 2025) to 1.13 Cr., marking an increase of 0.22 Cr..
- For Total Assets, as of Sep 2025, the value is 108.27 Cr.. The value appears strong and on an upward trend. It has increased from 96.19 Cr. (Mar 2025) to 108.27 Cr., marking an increase of 12.08 Cr..
Notably, the Reserves (102.45 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.32 | -0.17 | -0.15 | 0.22 | 2.38 | 0.54 | 4.98 | 0.91 | 4.06 | 5.48 | 7.12 | 1.95 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventory Days | 5,840.00 | |||||||||||
| Days Payable | 0.00 | |||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Working Capital Days | 1,095.00 | 344.72 | 92.61 | 43.80 | 91.25 | 16.80 | 57.48 | 13.85 | 10.59 | 13.00 | 16.00 | |
| ROCE % | -2.36% | -0.11% | 0.22% | 2.96% | 22.91% | 4.69% | 35.69% | 2.05% | 2.37% | 2.39% | 4.04% | 2.46% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 6.22 | 14.03 | 10.40 | 8.20 | 1.52 |
| Diluted EPS (Rs.) | 6.22 | 14.03 | 10.40 | 8.20 | 1.52 |
| Cash EPS (Rs.) | 6.22 | 14.04 | 10.40 | 8.21 | 1.53 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 211.65 | 361.74 | 421.96 | 598.23 | 162.63 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 211.65 | 361.74 | 421.96 | 598.23 | 162.63 |
| Dividend / Share (Rs.) | 1.00 | 6.00 | 5.00 | 4.00 | 1.00 |
| Revenue From Operations / Share (Rs.) | 5.55 | 16.85 | 13.01 | 9.96 | 2.81 |
| PBDIT / Share (Rs.) | 7.05 | 15.82 | 12.16 | 9.01 | 2.05 |
| PBIT / Share (Rs.) | 7.04 | 15.81 | 12.16 | 9.00 | 2.04 |
| PBT / Share (Rs.) | 7.04 | 15.81 | 12.16 | 9.00 | 2.04 |
| Net Profit / Share (Rs.) | 6.21 | 14.03 | 10.40 | 8.20 | 1.52 |
| PBDIT Margin (%) | 126.84 | 93.90 | 93.47 | 90.47 | 72.83 |
| PBIT Margin (%) | 126.73 | 93.86 | 93.42 | 90.40 | 72.56 |
| PBT Margin (%) | 126.73 | 93.86 | 93.42 | 90.40 | 72.56 |
| Net Profit Margin (%) | 111.87 | 83.27 | 79.89 | 82.37 | 54.15 |
| Return on Networth / Equity (%) | 2.93 | 3.87 | 2.46 | 1.37 | 0.93 |
| Return on Capital Employeed (%) | 3.29 | 4.34 | 2.86 | 1.50 | 1.25 |
| Return On Assets (%) | 2.90 | 3.85 | 2.45 | 1.36 | 0.93 |
| Asset Turnover Ratio (%) | 0.01 | 0.04 | 0.02 | 0.02 | 0.02 |
| Current Ratio (X) | 21693.05 | 181301.78 | 135791.86 | 269365.90 | 93947.72 |
| Quick Ratio (X) | 21645.64 | 181069.67 | 135650.00 | 269194.10 | 93743.94 |
| Inventory Turnover Ratio (X) | 11.98 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 96.53 | 35.64 | 38.47 | 12.19 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 96.43 | 35.62 | 38.44 | 12.18 | 0.00 |
| Earning Retention Ratio (%) | 3.47 | 64.36 | 61.53 | 87.81 | 0.00 |
| Cash Earning Retention Ratio (%) | 3.57 | 64.38 | 61.56 | 87.82 | 0.00 |
| Enterprise Value (Cr.) | 45.95 | 66.44 | 47.61 | 46.14 | 14.39 |
| EV / Net Operating Revenue (X) | 18.37 | 8.76 | 8.13 | 10.29 | 11.38 |
| EV / EBITDA (X) | 14.48 | 9.33 | 8.69 | 11.38 | 15.62 |
| MarketCap / Net Operating Revenue (X) | 18.38 | 8.76 | 8.14 | 10.33 | 11.46 |
| Retention Ratios (%) | 3.46 | 64.35 | 61.52 | 87.80 | 0.00 |
| Price / BV (X) | 0.48 | 0.40 | 0.25 | 0.17 | 0.19 |
| Price / Net Operating Revenue (X) | 18.38 | 8.76 | 8.14 | 10.34 | 11.46 |
| EarningsYield | 0.06 | 0.09 | 0.09 | 0.07 | 0.04 |
After reviewing the key financial ratios for Morarka Finance Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 6.22. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 6.22, marking a decrease of 7.81.
- For Diluted EPS (Rs.), as of Mar 25, the value is 6.22. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 6.22, marking a decrease of 7.81.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.22. This value is within the healthy range. It has decreased from 14.04 (Mar 24) to 6.22, marking a decrease of 7.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 211.65. It has decreased from 361.74 (Mar 24) to 211.65, marking a decrease of 150.09.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 211.65. It has decreased from 361.74 (Mar 24) to 211.65, marking a decrease of 150.09.
- For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 6.00 (Mar 24) to 1.00, marking a decrease of 5.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 5.55. It has decreased from 16.85 (Mar 24) to 5.55, marking a decrease of 11.30.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 7.05. This value is within the healthy range. It has decreased from 15.82 (Mar 24) to 7.05, marking a decrease of 8.77.
- For PBIT / Share (Rs.), as of Mar 25, the value is 7.04. This value is within the healthy range. It has decreased from 15.81 (Mar 24) to 7.04, marking a decrease of 8.77.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.04. This value is within the healthy range. It has decreased from 15.81 (Mar 24) to 7.04, marking a decrease of 8.77.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 6.21. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 6.21, marking a decrease of 7.82.
- For PBDIT Margin (%), as of Mar 25, the value is 126.84. This value is within the healthy range. It has increased from 93.90 (Mar 24) to 126.84, marking an increase of 32.94.
- For PBIT Margin (%), as of Mar 25, the value is 126.73. This value exceeds the healthy maximum of 20. It has increased from 93.86 (Mar 24) to 126.73, marking an increase of 32.87.
- For PBT Margin (%), as of Mar 25, the value is 126.73. This value is within the healthy range. It has increased from 93.86 (Mar 24) to 126.73, marking an increase of 32.87.
- For Net Profit Margin (%), as of Mar 25, the value is 111.87. This value exceeds the healthy maximum of 10. It has increased from 83.27 (Mar 24) to 111.87, marking an increase of 28.60.
- For Return on Networth / Equity (%), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 15. It has decreased from 3.87 (Mar 24) to 2.93, marking a decrease of 0.94.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.29. This value is below the healthy minimum of 10. It has decreased from 4.34 (Mar 24) to 3.29, marking a decrease of 1.05.
- For Return On Assets (%), as of Mar 25, the value is 2.90. This value is below the healthy minimum of 5. It has decreased from 3.85 (Mar 24) to 2.90, marking a decrease of 0.95.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has decreased from 0.04 (Mar 24) to 0.01, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 21,693.05. This value exceeds the healthy maximum of 3. It has decreased from 181,301.78 (Mar 24) to 21,693.05, marking a decrease of 159,608.73.
- For Quick Ratio (X), as of Mar 25, the value is 21,645.64. This value exceeds the healthy maximum of 2. It has decreased from 181,069.67 (Mar 24) to 21,645.64, marking a decrease of 159,424.03.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 11.98. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 11.98, marking an increase of 11.98.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 96.53. This value exceeds the healthy maximum of 50. It has increased from 35.64 (Mar 24) to 96.53, marking an increase of 60.89.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 96.43. This value exceeds the healthy maximum of 50. It has increased from 35.62 (Mar 24) to 96.43, marking an increase of 60.81.
- For Earning Retention Ratio (%), as of Mar 25, the value is 3.47. This value is below the healthy minimum of 40. It has decreased from 64.36 (Mar 24) to 3.47, marking a decrease of 60.89.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 40. It has decreased from 64.38 (Mar 24) to 3.57, marking a decrease of 60.81.
- For Enterprise Value (Cr.), as of Mar 25, the value is 45.95. It has decreased from 66.44 (Mar 24) to 45.95, marking a decrease of 20.49.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 18.37. This value exceeds the healthy maximum of 3. It has increased from 8.76 (Mar 24) to 18.37, marking an increase of 9.61.
- For EV / EBITDA (X), as of Mar 25, the value is 14.48. This value is within the healthy range. It has increased from 9.33 (Mar 24) to 14.48, marking an increase of 5.15.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 18.38. This value exceeds the healthy maximum of 3. It has increased from 8.76 (Mar 24) to 18.38, marking an increase of 9.62.
- For Retention Ratios (%), as of Mar 25, the value is 3.46. This value is below the healthy minimum of 30. It has decreased from 64.35 (Mar 24) to 3.46, marking a decrease of 60.89.
- For Price / BV (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.40 (Mar 24) to 0.48, marking an increase of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 18.38. This value exceeds the healthy maximum of 3. It has increased from 8.76 (Mar 24) to 18.38, marking an increase of 9.62.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 24) to 0.06, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Morarka Finance Ltd:
- Net Profit Margin: 111.87%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.29% (Industry Average ROCE: 15.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 2.93% (Industry Average ROE: 8.76%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 21645.64
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 20.7 (Industry average Stock P/E: 36.97)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 111.87%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 511, Maker Chambers V, Mumbai Maharashtra 400021 | investors@morarkafinance.in http://www.morarkafinance.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. G R Morarka | Chairman |
| Ms. Priyanka G Morarka | Director |
| Ms. Divya Rao | Director |
| Mr. Arun Kumar Tulsian | Director |
| Ms. Nina Chatrath | Director |
| Ms. K Savitha Rao | Director |
FAQ
What is the intrinsic value of Morarka Finance Ltd?
Morarka Finance Ltd's intrinsic value (as of 12 December 2025) is 86.52 which is 0.84% higher the current market price of 85.80, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 38.6 Cr. market cap, FY2025-2026 high/low of 165/74.8, reserves of ₹102.45 Cr, and liabilities of 108.27 Cr.
What is the Market Cap of Morarka Finance Ltd?
The Market Cap of Morarka Finance Ltd is 38.6 Cr..
What is the current Stock Price of Morarka Finance Ltd as on 12 December 2025?
The current stock price of Morarka Finance Ltd as on 12 December 2025 is 85.8.
What is the High / Low of Morarka Finance Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Morarka Finance Ltd stocks is 165/74.8.
What is the Stock P/E of Morarka Finance Ltd?
The Stock P/E of Morarka Finance Ltd is 20.7.
What is the Book Value of Morarka Finance Ltd?
The Book Value of Morarka Finance Ltd is 238.
What is the Dividend Yield of Morarka Finance Ltd?
The Dividend Yield of Morarka Finance Ltd is 1.16 %.
What is the ROCE of Morarka Finance Ltd?
The ROCE of Morarka Finance Ltd is 2.46 %.
What is the ROE of Morarka Finance Ltd?
The ROE of Morarka Finance Ltd is 2.17 %.
What is the Face Value of Morarka Finance Ltd?
The Face Value of Morarka Finance Ltd is 10.0.